Case series:Apatinib Mesylate Tablets

4 trials

Sponsors

The First Affiliated Hospital of Wenzhou Medical University, the First affiliated Hospital of SooChow University

Conditions

cancerovarian cancer

Phase 2

The phase ? study of Apatinib in treating patients with advanced/recurrent ovarian cancer

RecruitingChiCTR-OIC-17010304

The First Affiliated Hospital of Wenzhou Medical Universityovarian cancer

Start: 2017-01-01Updated: 2017-04-18

Phase 4

A exploratory controlled clinical study of Apatinib combined TACE in treating advanced hepatocellular carcinoma

RecruitingChiCTR-OPN-16009457

the First affiliated Hospital of SooChow Universitycancer

Start: 2016-10-01Updated: 2017-04-18

A study to determine the curative effect and mechanism of Apatinib combined with chemotherapy for SD patients with advanced malignant solid tumor

RecruitingChiCTR-OPC-16009849

the First affiliated Hospital of SooChow Universitycancer

Start: 2016-10-23Updated: 2017-04-18

The clinical study of Apatinib mesylate combined with Temozolomide in treating patients with recurrent high-grade glioma

RecruitingChiCTR-OPC-16010108

the First affiliated Hospital of SooChow Universitycancer

Start: 2016-11-25Updated: 2017-04-18